ABNOM
☆ AI Dermatology — Free Service
Dalam keputusan Stiftung Warentest 2022 dari Jerman, kepuasan pengguna terhadap ModelDerm hanya lebih rendah sedikit berbanding dengan perundingan teleperubatan berbayar.
Dalam keputusan Stiftung Warentest 2022 dari Jerman, kepuasan pengguna terhadap ModelDerm hanya lebih rendah sedikit berbanding dengan perundingan teleperubatan berbayar.
relevance score : -100.0%
ReferencesLaser Q‑switched Nd:YAG diketahui berkesan merawat nevus Ota dan keadaan yang serupa. Kami menjalankan kajian untuk menilai keberkesanan laser high‑fluence 1064 nm Q‑switched Nd:YAG pada bintik Mongolia yang luar biasa, tanpa menyebabkan kulit menjadi cerah. Sebanyak 61 pesakit dengan bintik‑bintik ini dianalisis, melibatkan 70 lesi. Separuh lesi dirawat dengan laser, manakala separuh lagi tidak dirawat sebagai kumpulan kawalan. Keputusan dinilai menggunakan skala serta peranti Mexameter® untuk mengukur tahap melanin. Pesakit dipantau selama purata 14 bulan dalam kumpulan rawatan dan 18 bulan dalam kumpulan pemerhatian. Pada akhir kajian, terdapat perbezaan yang ketara dalam skor skala dan tahap melanin antara kumpulan yang dirawat dan tidak dirawat, dengan kumpulan yang dirawat laser menunjukkan hasil yang lebih baik. Laser high‑fluence Q‑switched Nd:YAG, tanpa menyebabkan pencerahan kulit, terbukti berkesan dan selamat untuk merawat bintik Mongolia yang luar biasa ini.
The Q-switched Nd:YAG laser is known to effectively treat nevus of Ota and similar conditions. We conducted a study to see how well a high-fluence 1064 nm Q-switched Nd:YAG laser worked on Mongolian spots in unusual areas, without causing the skin to lighten. We studied 61 patients with these spots, examining a total of 70 lesions. Half of lesions were treated with the laser, while others were left untreated for comparison. We evaluated the results using a scale and a device called a Mexameter® to measure melanin levels. Patients were followed up for an average of 14 months in the treatment group and 18 months in the observation group. At the end of the study, we found significant differences in the scale scores and melanin levels between the treated and untreated groups, with the laser-treated group showing better outcomes. The high-fluence Q-switched Nd:YAG laser, without causing skin lightening, proved effective and safe for treating these unusual Mongolian spots.
The Q-switched Nd:YAG laser is known to effectively treat nevus of Ota and similar conditions. We conducted a study to see how well a high-fluence 1064 nm Q-switched Nd:YAG laser worked on Mongolian spots in unusual areas, without causing the skin to lighten. We studied 61 patients with these spots, examining a total of 70 lesions. Half of lesions were treated with the laser, while others were left untreated for comparison. We evaluated the results using a scale and a device called a Mexameter® to measure melanin levels. Patients were followed up for an average of 14 months in the treatment group and 18 months in the observation group. At the end of the study, we found significant differences in the scale scores and melanin levels between the treated and untreated groups, with the laser-treated group showing better outcomes. The high-fluence Q-switched Nd:YAG laser, without causing skin lightening, proved effective and safe for treating these unusual Mongolian spots.
Kami mengkaji keberkesanan dan keselamatan penggunaan rawatan laser khusus untuk ABNOM, serta faktor‑faktor yang mungkin mempengaruhi keberkesanan rawatan tersebut. Kami menilai 110 pesakit yang mempunyai ABNOM dan menerima antara dua hingga sembilan sesi rawatan laser. Kami mendapati bahawa rawatan lebih berkesan apabila dijalankan lebih lama, tetapi kurang berkesan pada pesakit yang lebih tua. Ia juga lebih berkesan pada pesakit dengan kulit lebih cerah (jenis III) dan kawasan terjejas yang lebih kecil (kurang daripada 10 cm²). Kehadiran melasma bersama ABNOM mengurangkan keberkesanan rawatan. Warna atau bilangan kawasan terjejas tidak menunjukkan perbezaan yang signifikan. Kira‑kira 10 % pesakit mengalami bintik‑bintik gelap selepas rawatan. Rawatan berganda pada peringkat awal memberikan hasil yang baik. Pesakit yang lebih tua dengan kulit lebih gelap serta bintik‑bintik gelap lebih berkemungkinan mengalami hiperpigmentasi selepas rawatan. Bagi pesakit ABNOM dan melasma, lebih baik menggunakan laser berkuasa rendah untuk mengelakkan melasma menjadi lebih teruk.
To evaluate the efficacy and safety of 1064-nm Q-switched Nd:YAG laser (QSNYL) therapy for ABNOM and to identify the factors influencing the outcome. A total of 110 patients with ABNOM were retrospectively evaluated and received two-to-nine treatment sessions. The curative effect was positively correlated with the treatment time and negatively correlated with the increasing age at first treatment (p < 0.05). The curative effect was better in patients with skin type III than those with type IV ( p < 0.05) and in patients with a lesion area of less than 10 cm2 than those with a larger affected area (p < 0.05). Additionally, the treatment effect was poorer in patients with concomitant melasma (p < 0.05). The treatment effect was not significantly correlated with the lesion color or number of affected sites (p > 0.05). Eleven patients (10%) developed postinflammatory hyperpigmentation (PIH). Early and repeated QSNYL therapy achieved satisfactory results for ABNOM. The risk of PIH after laser treatment is highest among patients with older age, darker lesion color, and darker skin color. For patients with ABNOM with concurrent melasma, low-energy laser therapy is recommended to reduce the risk of melasma aggravation.
To evaluate the efficacy and safety of 1064-nm Q-switched Nd:YAG laser (QSNYL) therapy for ABNOM and to identify the factors influencing the outcome. A total of 110 patients with ABNOM were retrospectively evaluated and received two-to-nine treatment sessions. The curative effect was positively correlated with the treatment time and negatively correlated with the increasing age at first treatment (p < 0.05). The curative effect was better in patients with skin type III than those with type IV ( p < 0.05) and in patients with a lesion area of less than 10 cm2 than those with a larger affected area (p < 0.05). Additionally, the treatment effect was poorer in patients with concomitant melasma (p < 0.05). The treatment effect was not significantly correlated with the lesion color or number of affected sites (p > 0.05). Eleven patients (10%) developed postinflammatory hyperpigmentation (PIH). Early and repeated QSNYL therapy achieved satisfactory results for ABNOM. The risk of PIH after laser treatment is highest among patients with older age, darker lesion color, and darker skin color. For patients with ABNOM with concurrent melasma, low-energy laser therapy is recommended to reduce the risk of melasma aggravation.
○ Rawatan
Agen pemutih jarang membantu. Tidak seperti melasma, ABNOM boleh diperbaiki dengan rawatan laser dan dibiarkan menghilang tanpa berulang. Rawatan laser boleh dilakukan 10 hingga 20 kali untuk merawat ABNOM.
#QS1064 laser